Shire to submit new drug application to FDA for dry eye disease.
- Published in:
- Optometry Times, 2014, v. 6, n. 6, p. 6
- Publication type:
- Article
Works matching DE "SHIRE Pharmaceuticals Group PLC"
Results: 40
1
2
Pipeline preview.
- Published in:
- Formulary, 2009, v. 44, n. 9, p. 261
- Publication type:
- Article
3
New formulations.
- Published in:
- Formulary, 2006, v. 41, n. 5, p. 213
- Publication type:
- Article
4
FDA actions in brief.
- Published in:
- Formulary, 2004, v. 39, n. 12, p. 571
- Publication type:
- Article
5
Product News.
- Published in:
- Nursing & Residential Care, 2005, v. 7, n. 9, p. 423
- Publication type:
- Article
6
Product News.
- Published in:
- 2005
- Publication type:
- Product Review
7
News briefing: 6–12 August 2010.
- Published in:
- Nature, 2010, v. 466, n. 7308, p. 800, doi. 10.1038/466800a
- Publication type:
- Article
8
Shire's Xiidra now widely available in U.S.
- Published in:
- 2016
- Publication type:
- Product Review
9
Public health, clinical research, embracing the outdoors.
- Published in:
- 2015
- By:
- Publication type:
- Interview
10
Attracting Long-Term Investors Through Integrated Thinking and Reporting: A Clinical Study of a Biopharmaceutical Company.
- Published in:
- Journal of Applied Corporate Finance, 2014, v. 26, n. 2, p. 57, doi. 10.1111/jacf.12067
- By:
- Publication type:
- Article
11
In a rare deal, Shire buys Dyax.
- Published in:
- TCE: The Chemical Engineer, 2015, n. 894/895, p. 7
- Publication type:
- Article
12
Product Update.
- Published in:
- 2006
- Publication type:
- Product Review
13
Adderall XR Shows Positive Effects on ADHD Symptoms.
- Published in:
- Journal of Psychosocial Nursing & Mental Health Services, 2006, v. 44, n. 1, p. 12
- Publication type:
- Article
14
Reminyl.
- Published in:
- Nurse Prescribing, 2006, v. 4, n. 5, p. 214
- Publication type:
- Article
15
Sound bites.
- Published in:
- Gastrointestinal Nursing, 2007, v. 5, n. 10, p. 6
- Publication type:
- Article
16
FDA: A NEW STRIPE OF ADHD TREATMENT FOR CHILDREN.
- Published in:
- Contemporary Pediatrics, 2009, v. 26, n. 10, p. 18
- Publication type:
- Article
17
Investigational MAS for adult ADHD.
- Published in:
- Brown University Psychopharmacology Update, 2007, v. 18, n. 2, p. 8
- Publication type:
- Article
18
Sales of Adderall XR in Canada to resume.
- Published in:
- Brown University Psychopharmacology Update, 2005, v. 16, n. 11, p. 7
- Publication type:
- Article
19
TAKEDA AGREES TO $62 BILLION TAKEOVER OF SHIRE.
- Published in:
- Applied Clinical Trials, 2018, v. 27, n. 6, p. 13
- Publication type:
- Article
20
Subjects Share the Same Concerns.
- Published in:
- 2012
- Publication type:
- Interview
21
Shire bags NPS, including newly approved biologic for hypoparathyroidism.
- Published in:
- Nature Biotechnology, 2015, v. 33, n. 3, p. 226, doi. 10.1038/nbt0315-226c
- Publication type:
- Article
22
Shire drops 'emergency' Fabry's disease drug.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 6, p. 478, doi. 10.1038/nbt0612-478c
- By:
- Publication type:
- Article
23
Once-daily MMX® mesalamine for endoscopic maintenance of remission of ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 1, p. 22
- By:
- Publication type:
- Article
24
Companies, technology & environment.
- Published in:
- Chemistry & Industry, 2011, n. 6, p. 15
- By:
- Publication type:
- Article
25
Science briefs.
- Published in:
- Chemistry & Industry, 2007, n. 22, p. 11
- Publication type:
- Article
26
Acquisitions underway.
- Published in:
- Chemistry & Industry, 2005, n. 9, p. 4
- By:
- Publication type:
- Article
27
From the FDA.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2007, v. 9, n. 4, p. 8
- Publication type:
- Article
28
from the FDA.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2006, v. 8, n. 11, p. 8
- Publication type:
- Article
29
Sales of Adderall XR to resume.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2005, v. 7, n. 10, p. 8
- Publication type:
- Article
30
FDA expected to approve MPH transdermal system by year's end.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2005, v. 7, n. 7, p. 1
- Publication type:
- Article
31
Methylphenidate transdermal patch for ADHD: positive clinical data.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2005, v. 7, n. 5, p. 8
- Publication type:
- Article
32
Health Canada suspends Adderall.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2005, v. 7, n. 3, p. 12
- Publication type:
- Article
33
News Update.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2002, v. 4, n. 1, p. 8
- Publication type:
- Article
34
News Update.
- Published in:
- Brown University Child & Adolescent Psychopharmacology Update, 2001, v. 3, n. 11, p. 7
- Publication type:
- Article
35
Etodolac (Lodine[sup ®]): Profile of an established selective COX-2 inhibitor.
- Published in:
- Inflammopharmacology, 2001, v. 9, n. 1/2, p. 63, doi. 10.1163/156856001300248335
- By:
- Publication type:
- Article
36
Pandemic plan: is the vaccine supply secure?
- Published in:
- 2004
- By:
- Publication type:
- journal article
37
FDA Takes Slow Road Toward Withdrawal of Drug Approved With Fast-Track Process.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 10, p. 982, doi. 10.1001/jama.2011.269
- By:
- Publication type:
- Article
38
Shire dumps Dynepo.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 12, p. 1322, doi. 10.1038/nbt1208-1322c
- By:
- Publication type:
- Article
39
HAE market heats up.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 9, p. 958, doi. 10.1038/nbt0908-958a
- By:
- Publication type:
- Article
40
Acquisition signals shift from US market.
- Published in:
- Nature Biotechnology, 2005, v. 23, n. 6, p. 635, doi. 10.1038/nbt0605-635
- By:
- Publication type:
- Article